Rais; Rana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rais; Rana.The latest application filed is for "prodrugs of hydroxamate-based gcpii inhibitors".

Company Profile

13.10.16

Rais; Rana - West Friendship MD
Rais; Rana - Kingsville MD
Rais; Rana - Baltimore MD
RAIS; RANA - OWINGS MILLS MD
Rais; Rana - West Firendship MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Buccal, sublingual and intranasal delivery of fospropofol Grant 11,331,271 - Slusher , et al. May 17, 2	2022-05-17
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Grant 11,325,931 - Slusher , et al. May 10, 2	2022-05-10
Prodrugs Of Hydroxamate-based Gcpii Inhibitors App 20210355079 - Slusher; Barbara ; et al.	2021-11-18
Prodrug compositions and utility of hydroxamate-based GCPII inhibitors Grant 11,059,775 - Slusher , et al. July 13, 2	2021-07-13
Mebendazole Prodrugs With Enhanced Solubility And Oral Bioavailability App 20210205271 - Slusher; Barbara ; et al.	2021-07-08
Prodrugs Of Glutamine Analogs App 20210206787 - SLUSHER; Barbara ; et al.	2021-07-08
Dendrimer Compositions And Methods For Drug Delivery App 20210170040 - Cleland; Jeffrey ; et al.	2021-06-10
Prodrugs of glutamine analogs Grant 10,954,257 - Slusher , et al. March 23, 2	2021-03-23
Prodrugs Of Prostate Specific Membrane Antigen (psma) Inhibitor App 20200399298 - SLUSHER; BARBARA ; et al.	2020-12-24
Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitors Grant 10,849,915 - Slusher , et al. December 1, 2	2020-12-01
Buccal, Sublingual And Intranasal Delivery Of Fospropofol App 20200289404 - Slusher; Barbara ; et al.	2020-09-17
Prodrugs of glutamine analogs Grant 10,738,066 - Slusher , et al. A	2020-08-11
Prodrugs Of 2-pmpa For Healthy Tissue Protection During Psma-targeted Cancer Imaging Or Radiotherapy App 20200069706 - Slusher; Barbara ; et al.	2020-03-05
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Grant 10,544,176 - Slusher , et al. Ja	2020-01-28
Novel Prodrug Compositions And Utility Of Hydroxamate-based Gcpii Inhibitors App 20190352255 - Slusher; Barbara ; et al.	2019-11-21
Prodrugs Of Glutamine Analogs App 20190315783 - Slusher; Barbara ; et al.	2019-10-17
Prodrugs Of Glutamine Analogs App 20190315784 - Slusher; Barbara ; et al.	2019-10-17
Prodrugs of glutamine analogs Grant 10,336,778 - Slusher , et al.	2019-07-02
Methods For Treating Inflammatory Bowel Disease Using Prostate Specific Membrane Antigen (psma) Inhibitors App 20190076447 - Slusher; Barbara ; et al.	2019-03-14
Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitors Grant 10,172,873 - Slusher , et al. J	2019-01-08
Intranasal Administration Of Glutamate Carboxypeptidase (gcp-ii) Inhibitors App 20180338910 - SLUSHER; BARBARA S. ; et al.	2018-11-29
Prodrugs Of Prostate Specific Membrane Antigen (psma) Inhibitor App 20180244705 - SLUSHER; BARBARA ; et al.	2018-08-30
Prodrugs Of Glutamine Analogs App 20180222930 - Slusher; Barbara ; et al.	2018-08-09
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Grant 9,988,407 - Slusher , et al. June 5, 2	2018-06-05
Methods For Treating Inflammatory Bowel Disease Using Prostate Specific Membrane Antigen (psma) Inhibitors App 20170224709 - SLUSHER; BARBARA ; et al.	2017-08-10
Prodrugs Of Prostate Specific Membrane Antigen (psma) Inhibitor App 20170226141 - SLUSHER; Barbara ; et al.	2017-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.